Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: sites default files 29071 DiBeneditti 2018 Conducting patient interviews within a clinical trial setting pdf
… Data Discoveries: The Nexus Between In-Study, Post-Study Interviews, and Traditional eCOA Data Capture." 1:30-2:00pm … Data Discoveries: The Nexus Between In-Study, Post-Study Interviews, and Traditional eCOA Data Capture. …
… V, Davidson D, Kalirai S, Wolin D, Boyle K, Seigel L. Patient-reported symptom burden in chronic inducible … urticaria: post hoc analysis of baseline data from a phase 3 clinical trial. Whalley D, Balp M, Yarr S, Porter M, Barve …
… Oncology A Wealth of Experience We have collaborated with our clients … studies Epidemiology of disease Exploratory analyses of clinical trial data Global and country-specific value … in clinical trials Literature reviews Measurement of patient preferences for treatment options Meta-analysis …
… Informing Gestational Age in Pregnancy Research without Clinical Estimates Distribution of gestational age by … data: toward informing gestational age assumptions when clinical estimates are not available. Margulis AV, Calingaert … age at birth that could inform assumptions when clinical estimates of gestational age at birth are not …
… activator (IV tPA) treatment would be offset by improved clinical outcomes. CHALLENGE We needed to address the lack of … CTP selection and penumbra-based MRI selection in a patient population like that enrolled in the IV tPA …
… D, Perez-Nieves M, Vass C , Poon JL, Gelsey FT, Pierce A, Mansfield C. Poster Preferences of people with type 1 … C , Poon JL, Schapiro D, Pierce A, Mansfield C. Poster Patient reported burden of disease in diabetic peripheral … neuropathic pain: learnings from in-depth patient interviews, sub-study of RELIEF-DPN 1. Gaudiani L, Gopinathan …
… stage of your product’s lifecycle, we can help you develop a strategic roadmap to effectively demonstrate and communicate your product’s value . For clinical and commercial teams alike, we provide extensive … strategy, we can help you develop and execute a plan that includes: Environmental Scans: Commercial, …
… options—lisdexamfetamine dimesylate (LDX) or atomoxetine. A recent study by two RTI-HS researchers published in CNS … Josephine Mauskopf, PhD, using data from the head-to-head trial, showed that LDX is a cost-effective treatment option compared with atomoxetine …
… negotiations. Our team has negotiated with the FDA’s Clinical Outcome Assessments (COA) team and a wide variety of reviewing divisions on numerous occasions …
… skin toxicity during loncastuximab tesirine treatment in a phase 2 clinical trial (LOTIS-2). Spira A, Zhou X, Liao L, Yu E, Chen L, Lau …